Senseonics Holdings (SENS) Prices 22.727M Share Offering at $1.10/Sh

Senseonics Holdings, Inc. (NYSE: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the pricing of a registered underwritten public offering of 22,727,273 shares of its common stock at a price to the public of $1.10 per share. The gross proceeds from the offering are expected to be $25.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Senseonics. In addition, Senseonics has granted the underwriter a 30-day option to purchase up to an additional 3,409,090 shares of its common stock. All of the shares sold in the offering were sold by Senseonics. The offering is expected to close on July 22, 2019, subject to customary closing conditions. Senseonics expects to use the net proceeds from the offering for working capital and general corporate purposes.

Jefferies LLC is acting as sole book-running manager for the offering.

You May Also Be Interested In

• Definium Therapeutics plans $500M public share offering
• Lime seeks up to $1.66 billion valuation in US IPO
• Southern Co. (SO) PT Lowered to $99 at Jefferies